The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling

被引:15
|
作者
Likhite, Neah [1 ]
Jackson, Christopher A. [1 ]
Liang, Mao-Shih [2 ]
Krzyzanowski, Michelle C. [1 ]
Lei, Pedro [2 ]
Wood, Jordan F. [1 ]
Birkaya, Barbara [1 ]
Michaels, Kerry L. [1 ]
Andreadis, Stelios T. [2 ]
Clark, Stewart D. [3 ,4 ,5 ]
Yu, Michael C. [1 ]
Ferkey, Denise M. [1 ]
机构
[1] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA
[4] SUNY Buffalo, Dept Psychol, Buffalo, NY 14214 USA
[5] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14214 USA
基金
美国国家科学基金会;
关键词
CAENORHABDITIS-ELEGANS; C-ELEGANS; DORSAL STRIATUM; METHYLATION; LOCALIZATION; MECHANISMS; BEHAVIORS; BINDING; SENSITIVITY; ADDICTION;
D O I
10.1126/scisignal.aad0872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methylation regulates diverse functions of eukaryotic cells, including gene expression, the DNA damage response, and circadian rhythms. We showed that arginine residues within the third intracellular loop of the human D2 dopamine receptor, which are conserved in the DOP-3 receptor in the nematode Caenorhabditis elegans, were methylated by protein arginine methyltransferase 5 (PRMT5). By mutating these arginine residues, we further showed that their methylation enhanced the D2 receptor-mediated inhibition of cyclic adenosine monophosphate (cAMP) signaling in cultured human embryonic kidney (HEK) 293T cells. Analysis of prmt-5-deficient worms indicated that methylation promoted the dopamine-mediated modulation of chemosensory and locomotory behaviors in C. elegans through the DOP-3 receptor. In addition to delineating a previously uncharacterized means of regulating GPCR (heterotrimeric guanine nucleotide-binding protein-coupled receptor) signaling, these findings may lead to the development of a new class of pharmacological therapies that modulate GPCR signaling by changing the methylation status of these key proteins.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Arginine methylation of HSP90A by protein arginine methyltransferase PRMT5 promotes development of adult T-cell leukemia
    Ichikawa, Tomonaga
    Shanab, Obeid
    Nakahata, Shingo
    Ono, Masaya
    Iha, Hidekatsu
    Morishita, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 737 - 737
  • [22] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
    Maria Patrizia Mongiardi
    Mauro Savino
    Laura Bartoli
    Sara Beji
    Simona Nanni
    Fiorella Scagnoli
    Maria Laura Falchetti
    Annarita Favia
    Antonella Farsetti
    Andrea Levi
    Sergio Nasi
    Barbara Illi
    Scientific Reports, 5
  • [23] Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
    Yan, Fengting
    Alinari, Lapo
    Lustberg, Mark E.
    Martin, Ludmila Katherine
    Cordero-Nieves, Hector M.
    Banasavadi-Siddegowda, Yeshavanth
    Virk, Selene
    Barnholtz-Sloan, Jill
    Bell, Erica Hlavin
    Wojton, Jeffrey
    Jacob, Naduparambil K.
    Chakravarti, Arnab
    Nowicki, Michal O.
    Wu, Xin
    Lapalombella, Rosa
    Datta, Jharna
    Yu, Bo
    Gordon, Kate
    Haseley, Amy
    Patton, John T.
    Smith, Porsha L.
    Ryu, John
    Zhang, Xiaoli
    Mo, Xiaokui
    Marcucci, Guido
    Nuovo, Gerard
    Kwon, Chang-Hyuk
    Byrd, John C.
    Chiocca, E. Antonio
    Li, Chenglong
    Sif, Said
    Jacob, Samson
    Lawler, Sean
    Kaur, Balveen
    Baiocchi, Robert A.
    CANCER RESEARCH, 2014, 74 (06) : 1752 - 1765
  • [24] Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling
    Chung, Jihyun
    Karkhanis, Vrajesh
    Baiocchi, Robert A.
    Sif, Said
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (19) : 7692 - 7710
  • [25] Efficacy of the protein arginine methyltransferase PRMT5 inhibitor GSK591 in glioma stem-like cells
    Shaw, Vikram
    Piao, Yuji
    Park, Soon Young
    Dong, Jianwen
    Martinez-Ledesma, Emmanuel
    Carrillo, Caroline
    Henry, Verlene
    Ezhilarasan, Ravesanker
    Sulman, Erik
    Balasubramaniyan, Veerakumar
    de Groot, John F.
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Dopamine D2-like receptor signaling suppresses human osteoclastogenesis
    Hanami, Kentaro
    Nakano, Kazuhisa
    Saito, Kazuyoshi
    Okada, Yosuke
    Yamaoka, Kunihiro
    Kubo, Satoshi
    Kondo, Masahiro
    Tanaka, Yoshiya
    BONE, 2013, 56 (01) : 1 - 8
  • [27] A role for protein arginine methyltransferase 5 (PRMT5) in the mechanism of novel anticancer agent, AS1411.
    Teng, Yun
    Bates, Paula J.
    CANCER RESEARCH, 2006, 66 (08)
  • [28] Negative regulation of transcription by the type II arginine methyltransferase PRMT5
    Fabbrizio, E
    El Messaoudi, S
    Polanowska, J
    Paul, C
    Cook, JR
    Lee, JH
    Nègre, V
    Rousset, M
    Pestka, S
    Le Cam, A
    Sardet, C
    EMBO REPORTS, 2002, 3 (07) : 641 - 645
  • [29] Protein Arginine Methyltransferase 5 (PRMT5) and the ERK1/2 & PI3K Pathways: A Case for PRMT5 Inhibition and Combination Therapies in Cancer
    Sapir, Tzuriel
    Shifteh, David
    Pahmer, Moshe
    Goel, Sanjay
    Maitra, Radhashree
    MOLECULAR CANCER RESEARCH, 2021, 19 (03) : 388 - 394
  • [30] Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
    Liu, Fan
    Cheng, Guoyan
    Hamard, Pierre-Jacques
    Greenblatt, Sarah
    Wang, Lan
    Man, Na
    Perna, Fabiana
    Xu, Haiming
    Tadi, Madhavi
    Luciani, Luisa
    Nimer, Stephen D.
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09): : 3532 - 3544